Your Notifications
All done, no notifications

What is a Tricuspid Atresia?

Tricuspid Atresia is a congenital heart defect in which the tricuspid valve does not form, preventing normal blood flow from the right atrium to the right ventricle. The right ventricle is often underdeveloped, and babies usually have an opening between the atria, such as an atrial septal defect, to allow blood to reach the left side of the heart. Other defects, including a ventricular septal defect or patent ductus arteriosus, may also help maintain blood flow to the lungs; symptoms and treatment depend on the amount of pulmonary blood flow and associated heart abnormalities.

What is the Importance of Timely Treatment?

Timely diagnosis and treatment are essential because tricuspid atresia can cause low oxygen levels, inadequate blood flow to the lungs, or excessive pulmonary blood flow that may damage the lung blood vessels. Early treatment helps support oxygen delivery, maintain appropriate blood flow, and reduce the risk of serious complications. Lifelong follow-up with a congenital heart specialist is necessary because complications may develop even after successful surgical treatment.

What are the Common Symptoms of Tricuspid Atresia?

  • Cyanosis: Bluish or greyish skin, lips, or nails may appear soon after birth because of low blood oxygen levels.
  • Breathing Difficulties: Rapid or difficult breathing may occur when the baby receives inadequate oxygen or has associated heart problems.
  • Poor Feeding: Babies may have difficulty feeding, tire easily during feeds, or take longer to feed.
  • Weak Pulse: Reduced oxygen delivery and impaired circulation may contribute to weak pulses.
  • Rapid Heartbeat: A fast heartbeat may occur as the heart attempts to maintain adequate circulation.
  • Poor Weight Gain: Babies with significant congenital heart disease may have difficulty gaining weight and growing normally.

Causes and Risk Factors of Tricuspid Atresia

Causes

  • Tricuspid atresia develops during fetal heart formation when the tricuspid valve does not form normally.
  • The exact cause is usually unknown. Genetic factors and interactions between inherited susceptibility and environmental influences may contribute to some congenital heart defects.
  • Tricuspid atresia may occur alone or alongside other structural abnormalities of the heart.

Risk Factors

  • A family history of congenital heart disease.
  • Certain genetic or chromosomal conditions.
  • Maternal diabetes or other health conditions during pregnancy.
  • Certain environmental exposures or medication-related factors during pregnancy.

Latest Research and Technologies in the Treatment of Tricuspid Atresia in Malaysia

Recent advances in treating tricuspid atresia in Malaysia include improved fetal and postnatal echocardiography, specialised paediatric cardiac intensive care, and staged surgical procedures tailored to the child's heart anatomy. Treatment may involve an initial shunt or other procedure to manage blood flow, followed by the bidirectional Glenn procedure and Fontan operation to improve circulation in children with single-ventricle physiology. Long-term monitoring helps detect complications such as abnormal heart rhythms, reduced heart function, or problems with the Fontan circulation. The treatment plan depends on the child's anatomy, oxygen levels, and overall condition.

Treatment options for Tricuspid Atresia

Ductal Stenting: In selected babies, a stent may be placed in the ductus arteriosus to maintain pulmonary blood flow and reduce the need for an early surgical shunt.

Systemic-to-Pulmonary Artery Shunt: A surgeon may create a shunt to increase blood flow to the lungs when the baby's anatomy requires more pulmonary blood flow.

Balloon Atrial Septostomy (BAS) : A cardiologist performs a BAS (also known as a Rashkind procedure). They insert a thin, flexible tube called a catheter into a blood vessel, usually in the groin, and thread it up to the heart.


Cost Start From 6500Explore Options

Pulmonary Artery Banding: If too much blood reaches the lungs, doctors may use pulmonary artery banding in selected patients to control pulmonary blood flow and protect the pulmonary circulation.

Bidirectional Glenn Operation : In this staged procedure, the superior vena cava is connected directly to the pulmonary arteries, allowing blood from the upper body to flow to the lungs without passing through the right ventricle.

Fontan Procedure : The final major stage of palliation connects venous blood from the lower body to the pulmonary arteries, allowing blood to reach the lungs without ventricular pumping. Selected patients may undergo a fenestration.

Heart Transplantation : Rarely, transplantation may be considered when the heart becomes severely weakened, the Fontan circulation fails, and other treatments are unsuitable.

  • Clinical assessment:
    • Prenatal assessment: Routine pregnancy ultrasound may identify a suspected heart abnormality. Fetal echocardiography provides a more detailed assessment of the heart's chambers, valves, blood vessels, and blood flow.
    • Medical and birth history: Doctors review pregnancy history, delivery details, feeding difficulties, breathing patterns, cyanosis, and any associated congenital conditions.
    • Physical examination: Assessment includes skin colour, breathing, heart sounds, pulses, oxygen saturation, and signs of poor circulation.
    • Electrocardiogram (ECG): Evaluates the heart's electrical activity and may identify rhythm abnormalities.
    • Blood tests: Blood gases, blood counts, glucose, electrolytes, and other investigations may be performed to assess the baby's condition and guide stabilisation.
  • Imaging Tests:
    • Fetal echocardiography: Helps identify tricuspid atresia before birth and supports delivery and treatment planning.
    • Transthoracic echocardiography: The main postnatal imaging test used to confirm the diagnosis and assess ventricular size, associated defects, valve anatomy, and pulmonary blood flow.
    • Chest X-ray: May show heart size and pulmonary blood flow.
    • Cardiac CT: May be used in selected cases to provide detailed anatomical information about blood vessels and associated abnormalities.
    • Cardiac MRI: Can assess heart structure, ventricular function, blood flow, and other features during selected follow-up evaluations.
    • Cardiac catheterisation: Measures pressures and oxygen levels in the heart and blood vessels and may also be used to perform interventions.

MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive tele-rehabilitation services designed to support Tricuspid Atresia patients in Malaysia. These services include:

  • Cardiac Rehabilitation: Selected children and adults may benefit from structured rehabilitation according to cardiac function and treatment history.
  • Gradual Physical Activity: Increase activity according to oxygen levels, ventricular function, symptoms, rhythm status, and congenital heart specialist advice.
  • Paediatric Developmental Support: Children with complex congenital heart disease may require developmental assessment and early supportive interventions.
  • Occupational Therapy: Selected children may benefit from support with age-appropriate functional activities and independence.
  • Exercise Assessment: Older children and adults may undergo exercise testing to guide safe physical activity.
  • Long-Term Congenital Heart Follow-Up: Regular specialist assessments help monitor ventricular function, oxygen levels, rhythm, Fontan circulation, liver health, exercise capacity, and other potential complications.
  • Medicines for tricuspid atresia depend on the patient's circulation, oxygen levels, ventricular function, and stage of treatment. Other medicines, including diuretics or medications that support heart function, may be prescribed as needed. After surgery, selected patients may require medicines to manage heart rhythm, fluid retention, or the risk of blood clots.

Instantly Connect with our Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8

Hospitals for Tricuspid Atresia in Malaysia

Ara Damansara Medical Centre: Top Doctors, and Reviews
Ara Damansara Medical Centre

Kuala Lumpur, Malaysia

Situated at the junction of Petaling Jaya and Shah Alam, close to the Oasis Ara, Ara Damansara Medical Centre boasts a serene, luxurious ambiance.

The Centre has been awarded several prestigious awards such as the Global Health Asia Pacific Awards 2023, Newsweek Best Specialized Hospital APAC 2023, Healthcare Asia Awards 2023, and Malaysian Healthcare Wellness Excellence.

Message Us
Subang Jaya Medical Centre: Top Doctors, and Reviews
Subang Jaya Medical Centre

Kuala Lumpur, Malaysia

Subang Jaya Medical Center is renowned for pioneering radiation oncology treatments and infrastructure in Malaysia. The hospital also has a state-of-the-art Cancer Radiosurgery Centre (CRC), which is fully furnished with the latest medical technology for cancer detection, monitoring, and treatment.

Message Us
ParkCity Medical Centre: Top Doctors, and Reviews
ParkCity Medical Centre

Kuala Lumpur, Malaysia

In Kuala Lumpur, Malaysia, ParkCity Medical Centre is a 300-bed, cutting-edge, interdisciplinary private hospital that provides award-winning private healthcare in an environment of lush vegetation.

Message Us

Our Services to better your experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Why Choose Malaysia for Tricuspid Atresia Treatment?

  • Experienced Paediatric Cardiac Specialists: Access to paediatric cardiologists, congenital heart surgeons, cardiac intensivists, and specialists experienced in complex congenital heart disease.
  • Advanced Newborn Cardiac Care: Specialised centres may provide neonatal intensive care, continuous monitoring, respiratory support, and urgent cardiovascular stabilisation.
  • Advanced Echocardiography: Fetal and postnatal echocardiography can support early diagnosis and treatment planning.
  • Cardiac Catheterisation Facilities: Eligible patients may have access to ductal stenting, diagnostic catheterisation, and other catheter-based procedures.
  • Staged Congenital Heart Surgery: Specialized centers can perform systemic-to-pulmonary shunts, Glenn procedures, Fontan procedures, and surgery for associated defects.
  • Multidisciplinary Heart Teams: Paediatric cardiologists, cardiac surgeons, intensivists, anaesthesiologists, imaging specialists, nurses, nutritionists, and rehabilitation professionals can coordinate complex care.
  • Long-Term Congenital Heart Follow-Up: Specialist programs can monitor patients from childhood into adulthood for Fontan-related complications, arrhythmias, ventricular function, and exercise capacity.
  • International Patient Support: Many major Malaysia hospitals assist international patients with medical records, appointments, treatment coordination, accommodation, and follow-up.

Frequently Asked Questions

Tricuspid atresia usually requires staged treatment rather than a single procedure. Recovery after each procedure varies, and the overall treatment pathway may extend through infancy and early childhood. Lifelong cardiac follow-up is required because the surgical procedures improve circulation but do not cure the underlying congenital heart defect.

A newborn with untreated tricuspid atresia may have critically low oxygen levels and requires urgent medical treatment rather than routine physical activity. After staged treatment, many children and adults can walk and remain active, but activity should be individualised according to oxygen saturation, ventricular function, heart rhythm, Fontan circulation, and specialist advice.

Many advanced Malaysia paediatric cardiac centres provide fetal and postnatal echocardiography, neonatal intensive care, cardiac catheterisation, ductal interventions, surgical shunts, Glenn and Fontan procedures, advanced cardiac imaging, and long-term congenital-heart follow-up.

Many major Malaysia hospitals have international patient departments that assist overseas families with medical records, appointments, treatment coordination, accommodation, interpretation where available, and follow-up arrangements. However, critically ill newborns require immediate local stabilisation and should not have urgent treatment delayed for international travel.

Choose a centre with experienced paediatric cardiologists, congenital heart surgeons, neonatal cardiac intensive care, and facilities for cardiac catheterisation and neonatal surgery. Ask about the team's experience with arterial switch operations, postoperative care, management of complications, and long-term congenital heart follow-up. The centre should be equipped to manage the baby's specific anatomy and clinical needs.

The success rate depends on the baby's anatomy, pulmonary blood flow, ventricular function, associated heart defects, oxygen levels, surgical stage, and postoperative complications. The treating congenital heart team can discuss expected outcomes based on the individual clinical condition

Specialised paediatric cardiac centres in Malaysia diagnose and treat congenital heart conditions, including TGA. Relevant services may include neonatal stabilisation, balloon atrial septostomy, arterial switch surgery, postoperative intensive care, and long-term follow-up. Families should confirm the treating team's experience with neonatal TGA and the specific procedure required.

Risks depend on the patient's condition and the procedure performed. Catheter-based procedures may involve bleeding, blood-vessel injury, infection, arrhythmias, or other complications. Surgical procedures may involve bleeding, infection, rhythm disturbances, blood clots, neurological complications, organ dysfunction, or problems with the surgical circulation.

Tricuspid atresia is a congenital heart condition, not an injury. If a newborn develops blue or grey skin, breathing difficulty, poor feeding, extreme sleepiness, or other signs of low oxygen, seek emergency medical care immediately. Tricuspid atresia is a critical congenital heart defect that may require urgent stabilisation and treatment soon after birth.

Tricuspid atresia does not directly cause physical or skeletal deformities. However, the condition and staged surgeries can be associated with long-term cardiac complications that may affect exercise capacity, development, or physical functioning. Lifelong congenital heart follow-up is important.

Yes. Tricuspid atresia and its treatment can affect exercise capacity, oxygen levels, daily activities, development, and overall well-being. Many people who undergo successful staged treatment can live active, productive lives, though they may still need ongoing medical care and guidance on activity.

Yes. Untreated tricuspid atresia can cause severe low oxygen levels, inadequate blood flow to the lungs and body, heart failure, and potentially life-threatening complications. Even after surgical treatment, patients require lifelong monitoring because arrhythmias, ventricular dysfunction, blood clots, fluid retention, and other complications may develop over time.

Tricuspid atresia develops during fetal heart formation and generally cannot be prevented. The exact cause is unknown in most cases. Appropriate prenatal care and management of maternal health conditions can support overall pregnancy health, while prenatal screening and fetal echocardiography may help identify the condition early.

Tricuspid atresia can occur in any pregnancy, and most cases do not have a clearly identifiable cause. Some congenital heart defects may be associated with genetic or chromosomal factors, but most babies with tricuspid atresia do not have a known preventable risk factor.

Author

Fauzia Zeb Fatima
Fauzia Zeb Fatima

M.Pharm

4 Years of Experience

Fauzia Zeb is a distinguished medical and scientific content writer with a robust academic foundation in pharmaceutical sciences, holding a B.Pharm and M.Pharm degree from prestigious institutions, including MIT and Jamia Hamdard University. Her comprehensive expertise in pharmacology, clinical sciences, and biomedical research enables her to translate complex medical and scientific concepts into precise, evidence-based content tailored for diverse audiences. Specializing in peer-reviewed articles, clinical blog posts, and research-driven publications, she demonstrates a consistent ability to bridge the gap between advanced medical science and accessible, audience-specific communication. View More

Reviewer

Dr. Nityanand Tripathi
Dr. Nityanand Tripathi

Interventional Cardiologist

29 Years of Experience

With a rich experience of more than 29 years, Dr. Nityanand has gained a vast spectrum of skills and expertise in performing all types of complex cardiac procedures. He is an expert in clinical & interventional cardiology and electrophysiology. He studied his medicine (MBBS) and MD from the Institute of Medical Sciences of Banaras Hindu University, Varanasi, and later completed his DM in Cardiology from the prestigious King George Medical University, Lucknow. View More

Last Reviewed - January 2026